US Patent Issued to DAIICHI SANKYO on June 9 for "Combination of antibody-pyrrolobenzodiazepine derivative conjugate and PARP inhibitor" (Japanese Inventors)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,648,946, issued on June 9, was assigned to DAIICHI SANKYO COMPANY Ltd. (Tokyo).

"Combination of antibody-pyrrolobenzodiazepine derivative conjugate and PARP inhibitor" was invented by Naoya Harada (Tokyo) and Michiko Kitamura (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition for treatment of cancer or a method for treating cancer, wherein an antibody-pyrrolobenzodiazepine derivative conjugate and a PARP inhibitor are administered in combination."

The patent was filed on March 26, 2020, under Application No. 17/442,608.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/ne...